RNA & DNA CDMO Services
Our mission and vision is to build the genomic based ecosystem and translate investment into innovation as we accelerate the impact of human health
First in class RNA/DNA manufacturing facility in middle-east with high-capacity production
One platform, infinite possibilities
RNA & DNA
CDMO Services
How it works
- Design of RNA product using proprietary algorithms
- Optimize sequences for various purposes
Antisense Oligo Design
Inhibits or alters protein expression
- Screening for target sequence
- Design of the sequence (chemical) modifications
- Characterization, (CE, LC-MS, Bioanalyzer)
- Formulation and lyophilization
mRNA Design
Translates to protein
- Therapeutic target (variant)
- The design of the sequence
- (chemical) modifications
Algorithms use combination of
- Our patented sequence-based de-immunization
- Codon-optimization to improve protein expression in the target tissue
- Proprietary 5` and 3`UTR libraries
Our Services
First in class RNA/DNA CDMO facility
High-capacity production in Middle-East
Significant drop in raw materials cost
Facilitate Gene Therapy pipeline
Readiness for any future pandemic
Global export opportunity
Founders and Advisors
Dr. Shima Gholizadeh
Founder & CEO
Dr. Ali Asadi
Co-founder & CSO
Dr. Alireza Haghighi
Senior Medical Advisor Academic Collab
Dr. Thomas Debray
Bioinformatics advisor Academic Collab
Mehrab Nademian
Business Development Expert
Dr. Marcus J. Jellen
Technical Advisor
Contact Us
Address based in California for KIMIAGEN BIOSCIENCES: 1051 Buena Vista Ave, Alameda, CA 94501